1.45
price down icon12.65%   -0.21
pre-market  Pre-market:  1.51   0.06   +4.14%
loading
Rani Therapeutics Holdings Inc stock is traded at $1.45, with a volume of 6.07M. It is down -12.65% in the last 24 hours and up +195.92% over the past month. Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
See More
Previous Close:
$1.66
Open:
$1.61
24h Volume:
6.07M
Relative Volume:
0.43
Market Cap:
$68.29M
Revenue:
$1.20M
Net Income/Loss:
$-52.41M
P/E Ratio:
-1.5934
EPS:
-0.91
Net Cash Flow:
$-31.25M
1W Performance:
-30.62%
1M Performance:
+195.92%
6M Performance:
+30.63%
1Y Performance:
-37.50%
1-Day Range:
Value
$1.42
$1.64
1-Week Range:
Value
$1.42
$2.18
52-Week Range:
Value
$0.387
$3.87

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
Name
Rani Therapeutics Holdings Inc
Name
Phone
(408) 457-3700
Name
Address
2051 RINGWOOD AVENUE, SAN JOSE
Name
Employee
106
Name
Twitter
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
RANI's Discussions on Twitter

Compare RANI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
1.45 79.51M 1.20M -52.41M -31.25M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
419.89 106.97B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
654.04 68.62B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.56 63.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
820.36 50.61B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
194.22 35.29B 398.11M -1.03B -868.57M -5.7032

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-02-24 Initiated Oppenheimer Outperform
Jun-14-24 Initiated Maxim Group Buy
Jun-13-24 Initiated Rodman & Renshaw Buy
Apr-17-23 Resumed BTIG Research Buy
Oct-11-22 Initiated UBS Buy
Jul-27-22 Initiated H.C. Wainwright Buy
Jun-13-22 Initiated Wedbush Outperform
View All

Rani Therapeutics Holdings Inc Stock (RANI) Latest News

pulisher
12:27 PM

Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025CEO Change & Daily Stock Trend Reports - newser.com

12:27 PM
pulisher
Oct 30, 2025

Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryTrend Reversal & Reliable Entry Point Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Short interest data insights for Rani Therapeutics Holdings Inc.Stop Loss & Intraday High Probability Setup Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Multi asset correlation models including Rani Therapeutics Holdings Inc.Market Growth Review & Weekly Market Pulse Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can momentum traders help lift Rani Therapeutics Holdings Inc.Earnings Performance Report & Weekly Sector Rotation Insights - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineOptions Play & AI Powered Market Entry Strategies - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is Rani Therapeutics Holdings Inc. stock a buy for dividend growth2025 Technical Overview & Daily Stock Trend Watchlist - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Rani Therapeutics (NASDAQ:RANI) Director Mir Imran Buys 2,083,334 Shares - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone - Markets Mojo

Oct 28, 2025
pulisher
Oct 28, 2025

Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Israel Englander, Ken Griffin, Michael Burry, Warren Buffett, ExodusPoint Capital, Rani Therapeutics Holdings Inc (RANI), Coca-Cola Co (KO), and More - Insider Monkey

Oct 28, 2025
pulisher
Oct 28, 2025

Institutional scanner results for Rani Therapeutics Holdings Inc.Weekly Market Summary & Weekly High Potential Stock Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Will Rani Therapeutics Holdings Inc. bounce back from current supportMarket Activity Report & Weekly Breakout Stock Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis tools2025 Macro Impact & Daily Volume Surge Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics director Imran Mir a buys $1.26 million in stock - Investing.com Philippines

Oct 27, 2025
pulisher
Oct 27, 2025

Technical analysis overview for Rani Therapeutics Holdings Inc. stockInsider Buying & Verified Entry Point Detection - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics director Imran Mir a buys $1.26 million in stock By Investing.com - Investing.com South Africa

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114 - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics appoints new directors and closes private placement By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics appoints new directors and closes private placement - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics Announces Board Changes - TradingView

Oct 27, 2025

Rani Therapeutics Holdings Inc Stock (RANI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.94
price up icon 0.74%
$92.59
price up icon 2.67%
$28.67
price down icon 0.97%
$104.67
price up icon 1.28%
biotechnology ONC
$308.22
price down icon 2.11%
$194.22
price up icon 16.33%
Cap:     |  Volume (24h):